Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.

European journal of human genetics : EJHG - 1 Feb 2009

Qiu Li-Xin, Li Ru-Tian, Zhang Jian-Bing, Zhong Wen-Zhao, Bai Jian-Ling, Liu Bao-Rui, Zheng Ming-Hua, Qian Xiao-Ping

Abstract excerpt

Published data on the association between E-cadherin (CDH1) -160 C/A polymorphism and prostate cancer (PCA) risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A logistic regression approach proposed for molecular association studies was used to estimate a biological model of the gene effect. A total of 11 studies including 2637 cases and 2673 controls...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to CDH1 gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Logistic Models

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 18781193
DOI: 10.1038/ejhg.2008.157
PMCID: PMC2986056

Genes

CDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.PMID 18781193Read ↗

E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.Semantic proximity Read ↗

The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.Semantic proximity Read ↗

Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.Semantic proximity Read ↗

Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.Semantic proximity Read ↗

The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.Semantic proximity Read ↗

Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.Semantic proximity Read ↗

E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.Semantic proximity Read ↗

-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.Semantic proximity Read ↗

Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.Semantic proximity Read ↗

E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.Semantic proximity Read ↗

The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.Semantic proximity Read ↗

Lack of Association between the CDH1 -160C>A Polymorphism and Risk of Gastrointestinal Cancer - a Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.